CMS authorizes ClearPractice for PQRI, e-prescribing

ClearPractice has been authorized by the Centers for Medicare & Medicaid Services (CMS), allowing eligible customers to qualify for a 2 percent reimbursement when they use the company’s e-prescribing tool and a 2 percent reimbursement for Physician Quality Reporting Initiative (PQRI) reporting through the patient registry within ClearPractice’s EMR.

ClearPractice configured its SaaS-based EMR technology to meet all the requirements for the 2010 PQRI registry and e-prescribing, according to the St. Louis-based company.

As an authorized PQRI registry, ClearPractice will submit data to CMS on behalf of eligible physicians based on PQRI quality measures. Similarly, CMS is offering a 2 percent incentive to providers who use e-prescribing technology to improve patient safety and reduce medication costs, ClearPractice stated.

ClearPractice's practice-automation suite includes the EMR and modules for patient health record, practice management, e-prescription, revenue cycle management and mobile applications.

    Around the web

    Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
     

    The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

    Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.